This Biotech Deal Is a $10 Billion Leap of Faith

Bookmark
(Bloomberg Opinion) -- Novartis AG’s latest biotech bolt-on requires a big leap of faith. The Swiss drugmaker’s $9.7 billion deal to buy Medicines Co. pays the U.S. cardiovascular specialist’s shar...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.